Advion Appoints Vice President International Business Development
News Oct 11, 2012
Advion, Inc. has announced the appointment of Vijay Gupta, PhD as Vice President International Business Development and Support focused on the expression compact mass spectrometer (CMS).
This continues Advion’s expansion within all areas of the organization from manufacturing, service/support and sales and marketing, which has accelerated since the Spring of 2012.
The CMS high performance single quadrupole mass spectrometer, introduced earlier this year, has achieved immediate success and significant orders from Asian markets, with volume from this region at more than twice the anticipated levels to date.
With a multi-channel distribution strategy that utilizes distributors, direct sales and OEM partners, Dr. Gupta will be responsible for managing and supporting these regional relationships, as well as engaging directly with customers to maximize the success of the broadening mass spec product lines.
As recognized by leading global instrument companies, Asia, South America and the Middle East represent a large base of industrial and academic synthetic chemists developing novel structures for medical and chemical purposes.
All of these scientists will benefit from the high performance, affordable, compact expression CMS.
Dr. Gupta is a seasoned professional in Advion’s organic chemistry markets having been a bench chemist himself, and serving as the head of International sales for many years at Biotage and Biolin.
“Many of our management team, Asian partners, and customers already know Vijay; his name is associated with the highest customer support, business ethics, and market/applications knowledge. We could not be more fortunate to have him aboard,” says David B. Patteson, President and CEO.
Patteson continued, “I will continue to be actively involved in these regions, but Vijay will be responsible for day-to-day activities and for leading the International strategy for the CMS. In Asia alone (outside of Japan), we have received more orders in the first six months of our fiscal year than were anticipated for the full year. We must add resources to support our channel partners and support the customers. It’s a great situation for us at this particular moment.”
The appointment of Dr. Gupta to Advion’s executive management team is the latest in the company’s more than 20% expansion in headcount to meet the fast-growing global demand for the new compact mass spectrometer.
In the most recent quarter ending September 30th, orders for the product more than tripled from the previous quarter, were 50% above plan, and are on a unit volume run rate approaching nearly 10% of the global single quadrupole market share in the first year following production launch.
A global training center and program will be initiated for all customers in November and benefit from the LC/MS knowledge backbone of the company.
“We took great care to develop the expression CMS, and the response from the marketplace has proven that the product has hit its mark with not only our target market, but in application areas we did not fully anticipate. We are now in the enviable position of keeping pace with the market,” concludes Mr. Patteson.
Bacteria Produce More Substances Than Genetics PredictedNews
Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.READ MORE
Lead and Other Toxic Metals Found in E-Cigarette 'Vapors'News
Significant amounts of toxic metals, including lead, leak from some e-cigarette heating coils and are present in the aerosols inhaled by users, according to a new study.READ MORE